BFEC
ATRC icon

Benjamin F. Edwards & Company’s AtriCure ATRC Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-868
Closed -$57K – 1678
2021
Q1 		$57K Buy
+868
New +$53.5K ﹤0.01% 965
2020
Q4 		– Sell
-1,125
Closed -$45K – 1596
2020
Q3 		$45K Buy
+1,125
New +$47.7K ﹤0.01% 919

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Benjamin F. Edwards & Company's ATRC Position: Q2 2021 in Review

Benjamin F. Edwards & Company sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 868 shares — an estimated $57K sold.

Benjamin F. Edwards & Company first reported a position in ATRC in Q3 2020 and held it in 2 quarters. The position peaked at $57K in Q1 2021. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

  • Benjamin F. Edwards & Company reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 868 AtriCure shares in Q2 2021, an estimated $57K.
  • Benjamin F. Edwards & Company first reported a position in AtriCure in Q3 2020 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's AtriCure position peaked at $57K in Q1 2021.
  • 212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2021, filed 11 Aug 2021.